CoreCap Advisors’s Ocugen OCGN Stock Holding History

CoreCap Advisors’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-474	Closed	-$335	–	3087
2025 Q1	$335	Buy	474 +464	+4,640%	+$321	﹤0.01%	2789
2024 Q4	$8	Buy	+10	New	+$9	﹤0.01%	2836

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rinkey Investments San Diego, California $425M AUM 14.99% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CoreCap Advisors's OCGN Position: Q2 2025 in Review

CoreCap Advisors sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 474 shares — an estimated $335 sold.

CoreCap Advisors first reported a position in OCGN in Q4 2024 and held it in 2 quarters. The position peaked at $335 in Q1 2025. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

CoreCap Advisors reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
CoreCap Advisors sold 474 Ocugen shares in Q2 2025, an estimated $335.
CoreCap Advisors first reported a position in Ocugen in Q4 2024 and held it in 2 quarters.
CoreCap Advisors's Ocugen position peaked at $335 in Q1 2025.
104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.